Gland Pharma Limited — Share Issue/Capital Change 2021

Jul 5, 2021

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

July 5, 2021

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor 25[th] floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 543245 Symbol : GLAND (ISIN : INE068V01023)

Sub: Allotment of Equity Shares on exercise of ESOP

Dear Sir/Madam,

This is to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; the ESOP Compensation Committee of the Board of Directors of the Company has allotted 332,450 Equity shares of Rs.1/- each of the Company, fully paid up, on July 5, 2021 to employees on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019.

Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,237,173/- comprising of 164,237,173 Equity shares of face value Rs.1/- each.

This is for your information and records.

Yours truly,

==> picture [217 x 108] intentionally omitted <==

Factory & Regd. Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads, D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Tel: +91-40-30510999 Fax; +91-40-30510800, email: gland@glandpharma.com | www.glandpharma.com CIN: L24239TG1978PLC002276